Rhythm Technologies News Today

Homestead Advisers Corp raised its stake in shares of iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report) by 103.2% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 12,800 shares of the company’s stock after purchasing an additional 6,500 shares during the period. Homestead Advisers Corp’s holdings in iRhythm […]

Evoke Wealth LLC acquired a new position in iRhythm Technologies, Inc. (NASDAQ:IRTC – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 13,255 shares of the company’s stock, valued at approximately $1,419,000. A number of other large investors […]

NEW YORK, May 21, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating...

The cardiac restoration systems market is expected to surge mainly driven by the increasing incidence of cardiovascular diseases, attributed to factors...

IRhythm Technologies (NASDAQ:IRTC – Free Report) had its price objective upped by Needham & Company LLC from $137.00 to $138.00 in a research report released on Friday morning, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. A number of other brokerages have also weighed in on IRTC. Canaccord Genuity […]

IRhythm Technologies (NASDAQ:IRTC – Free Report) had its price target lowered by Canaccord Genuity Group from $133.00 to $122.00 in a report released on Friday morning, Benzinga reports. The firm currently has a buy rating on the stock. Several other brokerages have also recently commented on IRTC. Needham & Company LLC raised their target price […]

IRhythm Technologies (NASDAQ:IRTC – Free Report) had its price objective raised by Needham & Company LLC from $137.00 to $138.00 in a research note released on Friday morning, Benzinga reports. Needham & Company LLC currently has a buy rating on the stock. A number of other brokerages have also issued reports on IRTC. JPMorgan Chase […]

IRhythm Technologies, Inc. (NASDAQ:IRTC) Q1 2024 Earnings Call Transcript May 4, 2024 iRhythm Technologies, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to the iRhythm Technologies, Inc. Q1 2024 Earnings Conference Call. My name is Terry, and […]

InvestorPlace - Stock Market News, Stock Advice & Trading Tips IRTC stock results show that iRhythm Technologies missed analyst estimates for earnings per…

Investment Analysts’ price target changes for Friday, May 3rd: Apple (NASDAQ:AAPL) had its target price increased by Monness Crespi & Hardt from $200.00 to $205.00. The firm currently has a buy rating on the stock. Apple (NASDAQ:AAPL) had its target price boosted by JPMorgan Chase & Co. from $210.00 to $225.00. They currently have an […]